CSG's First Earnings Since Listing Set to Test Credibility After Share Price Halved

CSG reports quarterly results as a public company amid short-seller attack, NATO ban, and EU financing deadline. Shares halved since January despite unanimous buy ratings.

The Prague-based defence group CSG enters a defining week. When it publishes quarterly results for the first time as a publicly traded company on May 20, the numbers will be measured against a drumbeat of governance accusations, a NATO procurement ban and a financing deadline in Brussels. All nine analysts covering the stock rate it a buy, yet the shares have lost more than half their value since the January peak.

On Friday, the stock closed at €16.42, just 4.4% above the year’s low hit on May 4. The chasm between that price and the 50-day moving average of roughly €23 shows how sharply momentum turned after the company’s market debut. The gap between broker targets — a consensus €35.40 and JPMorgan’s €40 — and the actual trading level is now nearly unprecedented in the European defence sector.

The short-seller attack that rattled investors

The slide began in earnest after Hunterbrook Media published a report on May 4 alleging that most of CSG’s ammunition revenue came from re-selling old munitions rather than producing new ones. The stock plunged 13% that day, triggering a temporary trading halt. The company has pushed back forcefully, describing the analysis as a mischaracterisation of its business model, disclosure practices and governance structure. Management points to a distributed, vertically integrated production network spanning multiple countries.

The operational facts are these: CSG produced roughly 630,000 rounds in-house in 2025, excluding restarted lines and partner capacity. It expects own production to rise by about 20% in 2026 and eventually reach 1.1 million rounds, with expansion focused on facilities in Slovakia, Greece, Serbia, Spain and India. The upcoming earnings report will allow investors to scrutinise those claims against hard data for the first time.

NATO exclusion list adds political weight

A separate headache emerged when the NATO Support and Procurement Agency put CSG’s Spanish subsidiary, Fábrica de Municiones de Granada, on an exclusion list linked to corruption investigations against current and former employees. The company insists a forensic audit cleared it of wrongdoing and that the ban only concerns NSPA procurement channels, not direct sales to individual NATO members. Still, the timing compounds the trust deficit.

The EU’s SAFE programme adds another layer of complexity. A seven-year Slovak framework contract for ammunition carries a maximum value of €58 billion and can be financed at just 1% interest on condition that at least two EU states participate. That favourable rate expires at the end of May 2026. So far Romania has denied that ministerial-level talks took place, and Croatia is still weighing whether to join. Without a second state, the financing terms become less generous, potentially delaying future orders for CSG.

Strong fundamentals sit beneath the storm

None of the political noise changes the underlying commercial trajectory. Revenue surged nearly 72% last year to €6.7 billion, and the order backlog stands at €42 billion, providing exceptional earnings visibility. Rating agencies are on board: Moody’s recently upgraded secured debt to Baa3, and Fitch affirmed its BBB- rating with a stable outlook.

The consensus from the sell side remains strikingly constructive. All nine analysts tracked recommend buying the stock. The average price target of €35.40 implies more than a doubling from current levels. That disconnect — between the market’s deep scepticism and the analysts’ conviction — is exactly what the May 20 numbers must begin to resolve.

What the market needs to see

The first-quarter report will put order intake, cash flow, margins and the production ramp-up under the microscope. Investors will also want clarity on one-off costs from the initial public offering that may have depressed recent profitability. Management has promised that the same level of transparency it showed during the listing process will continue.

After a 50% rout from the January high, CSG does not need grand promises. It needs data that matches the narrative of a vertically integrated, fast-growing defence manufacturer. If the earnings deliver that, the focus may finally shift from the short-seller controversy and political snags back to a business that analysts argue is worth double its current market price.